TS Harihar of HRBV Client Solutions is of the view that Glenmark Pharma can outperform and has a target price of Rs 1180-1200 in the next one quarter.
first published: Apr 16, 2015 10:30 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

